AbbVie Inc. (ABBV) Shareholders & Insider Trades
AbbVie shareholders at a glance
The largest holder of AbbVie stock is Vanguard Capital Management LLC, with 115.4 million shares (6.53% of the company), worth about $29.59 billion as of September 25, 2026. The 10 largest holders together own 32.9%.
In Q2 2026, 4,378 institutional holdings reports listed shares worth $361.00 billion.
Insiders reported 69 transactions in the last two years: 16 sales worth $89.23 million and no purchases. The newest one on file is from August 14, 2026 (Donoghoe Nicholas, Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through August 14, 2026.
AbbVie Inc.
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest AbbVie shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Vanguard Capital Management LLC | 115.4 million | 6.53% | $29.6B |
| BlackRock Advisors LLC | 110.7 million | 6.27% | $28.4B |
| State Street Corporation | 82.6 million | 4.67% | $21.2B |
| Vanguard Portfolio Management LLC | 48.5 million | 2.74% | $12.4B |
| JPMorgan Investment Management, Inc. | 47.9 million | 2.71% | $12.3B |
| Geode Capital Management LLC | 47.0 million | 2.66% | $12.1B |
| Eaton Vance Management | 38.9 million | 2.20% | $10.0B |
| BlackRock Life Ltd. | 34.5 million | 1.96% | $8.9B |
| Capital Research & Management Co. (Global Investors) | 30.1 million | 1.70% | $7.7B |
| Norges Bank (13F) | 25.6 million | 1.45% | $6.6B |
As of September 25, 2026.
AbbVie institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 4,378 | – | $361.0B |
| Q1 2026 | 4,244 | 1.30 billion | $282.0B |
| Q4 2025 | 4,301 | 1.33 billion | $303.0B |
| Q3 2025 | 4,069 | 1.33 billion | $307.0B |
| Q2 2025 | 3,930 | 1.30 billion | $242.0B |
| Q1 2025 | 3,963 | 1.29 billion | $271.0B |
| Q4 2024 | 3,890 | 1.29 billion | $230.0B |
| Q3 2024 | 3,646 | 1.33 billion | $268.0B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
AbbVie insider trades
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Donoghoe Nicholas | Aug 14, 2026 | Officer | Sale at price 250.00 per share. | $8.2M |
| Donoghoe Nicholas | Aug 14, 2026 | Officer | Conversion of Exercise of derivative security at price 79.02 per share. | $2.6M |
| Falk Thomas J | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Austin Roxanne Schuh | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Freyman Thomas C | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Waddell Frederick H | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Hart Brett J | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Rapp Edward J | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Burnside William H L | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Meyer Melody B | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Roberts Rebecca B. | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Quaggin Susan E | May 8, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 69 insider transactions in the last two years.
Questions and answers
Who owns the most AbbVie stock?
Vanguard Capital Management LLC, with 6.53% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.27%) and State Street Corporation (4.67%).
How many institutions own AbbVie stock?
4,378 institutional holdings reports listed AbbVie shares in Q2 2026 worth $361.00 billion.
Are AbbVie insiders buying or selling the stock?
In the last two years insiders reported 16 sales and no purchases (69 transactions in all); the newest on file is from August 14, 2026.
